We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.23B
AUM Growth
+$208M
Cap. Flow
+$22.5M
Cap. Flow %
0.53%
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181
Avg Time Held Equity + Options
4.4 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.6 quarters
Avg Time Held Equity only
4.5 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.6 quarters

Top Buys

Rank Stock Value
1
ITCI icon
Intra-Cellular Therapies Inc.
ITCI
+$383M
2
DFS icon
Discover Financial Services
DFS
+$224M
3
BECN icon
Beacon Roofing Supply, Inc.
BECN
+$183M
4
WBA icon
Walgreens Boots Alliance
WBA
+$110M
5
JWN icon
Nordstrom
JWN
+$95.8M

Top Sells

Rank Stock Value
1
HCP icon
HashiCorp, Inc. Class A Common Stock
HCP
+$235M
2
SMAR icon
Smartsheet Inc.
SMAR
+$216M
3
EDR icon
Endeavor Group Holdings, Inc.
EDR
+$144M
4
SUM icon
Summit Materials, Inc. Class A Common Stock
SUM
+$103M
5
ALTR icon
Altair Engineering Inc
ALTR
+$97.9M

Sector Composition

Rank Sector Weight
1 Energy 17.21%
2 Healthcare 16.93%
3 Financials 12.93%
4 Industrials 12.5%
5 Technology 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SPKL
201
DELISTED
Spark I Acquisition Corp
SPKL
$722K 0.02%
66,832
– –
2024 Q1
4 quarters
IRON icon
202
Disc Medicine
IRON
$2.38B
$676K 0.02%
13,621
-636
-4% -$35.4K
2023 Q1
8 quarters
NGNE icon
203
Neurogene
NGNE
$528M
$656K 0.02%
56,015
+23,281
+71% +$404K
2024 Q2
3 quarters
CHTR icon
204
PUT
Charter Communications
CHTR
$11.8B
$654K 0.02%
20,500
+12,100
+144% +$4.33M
2024 Q1
4 quarters
TSLA icon
205
Tesla
TSLA
$1.51T
$648K 0.02%
2,500
+2,000
+400% +$667K
2024 Q4
1 quarter
PTGX icon
206
Protagonist Therapeutics
PTGX
$9.3B
$645K 0.02%
+13,340
New +$559K
2025 Q1
0 quarters
HOG icon
207
PUT
Harley-Davidson
HOG
$2.8B
$642K 0.02%
240,000
+5,000
+2% +$134K
2023 Q3
6 quarters
AMD icon
208
Advanced Micro Devices
AMD
$993B
$616K 0.01%
+6,000
New +$667K
2025 Q1
0 quarters
PTON icon
209
PUT
Peloton Interactive
PTON
$2.25B
$588K 0.01%
290,500
-209,500
-42% -$1.64M
2023 Q1
8 quarters
OCFT
210
DELISTED
OneConnect Financial Technology
OCFT
$558K 0.01%
+83,257
New +$369K
2025 Q1
0 quarters
CC icon
211
PUT
Chemours
CC
$2.05B
$546K 0.01%
46,900
– –
2024 Q2
3 quarters
VERA icon
212
Vera Therapeutics
VERA
$2.15B
$541K 0.01%
22,525
+10,994
+95% +$353K
2023 Q1
8 quarters
ONC icon
213
BeOne Medicines Ltd
ONC
$40.1B
$512K 0.01%
1,880
-14,319
-88% -$3.35M
2024 Q3
2 quarters
TAL icon
214
TAL Education Group
TAL
$7.13B
$489K 0.01%
+37,000
New +$461K
2025 Q1
0 quarters
AZN icon
215
AstraZeneca
AZN
$247B
$486K 0.01%
3,306
-27,418
-89% -$3.97M
2024 Q4
1 quarter
META icon
216
PUT
Meta Platforms (Facebook)
META
$1.83T
$452K 0.01%
+16,000
New +$10.3M
2025 Q1
0 quarters
ROIV icon
217
Roivant Sciences
ROIV
$25.6B
$432K 0.01%
42,819
-136,447
-76% -$1.48M
2022 Q4
9 quarters
WRD icon
218
WeRide Inc
WRD
$1.58B
$425K 0.01%
+31,350
New +$535K
2025 Q1
0 quarters
VSAT icon
219
PUT
Viasat
VSAT
$9.92B
$425K 0.01%
73,300
– –
2024 Q2
3 quarters
JANX icon
220
Janux Therapeutics
JANX
$1.12B
$406K 0.01%
+15,040
New +$567K
2025 Q1
0 quarters
MLCO icon
221
Melco Resorts & Entertainment
MLCO
$1.61B
$405K 0.01%
+76,800
New +$432K
2025 Q1
0 quarters
LRMR icon
222
Larimar Therapeutics
LRMR
$277M
$387K 0.01%
180,027
-8,516
-5% -$26.9K
2022 Q4
9 quarters
BMRN icon
223
BioMarin Pharmaceuticals
BMRN
$10.6B
$372K 0.01%
5,258
-21,582
-80% -$1.45M
2024 Q4
1 quarter
LYV icon
224
PUT
Live Nation Entertainment
LYV
$39.7B
$370K 0.01%
32,500
-182,900
-85% -$25M
2023 Q3
6 quarters
HLF icon
225
PUT
Herbalife
HLF
$1.37B
$367K 0.01%
82,400
– –
2024 Q1
4 quarters
7 8
9
10 11

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2025 Portfolio in Review

As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

UBS O'Connor's Q1 2025 filing shows 83 new, 81 increased, 97 reduced and 181 closed positions. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M. The largest sale was HashiCorp, Inc. Class A Common Stock, an estimated $235M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
  • UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
  • UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
  • UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
  • UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
  • UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
  • UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.